Walking Ability and Limit of Stability in Children With Spastic Cerebral Palsy

an Investigation of the Relationship Between Walking Ability and Limit of Stability in Children With Spastic Cerebral Palsy

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05583929

Enrollment

Registered

2022-10-18

Start date

2022-11-29

Completion date

2024-06-01

Last updated

2022-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait, Spastic

Keywords

gait, walking ability, limit of stability, cerebral palsy

Brief summary

Trunk control in children with spastic Cerebral Palsy (CP) is impaired. They have weaker trunk muscle strenght, and insufficient sitting/standing balance according to their developing peers. Since their weak trunk muscles and insufficient balance responses, they are not able to walk as functional similar to their peers. Additionaly limit of stability is worsen in children with CP. Investigation of the relationship between walking ability and limit of stability when seated position is important to understand which child is acceptable for training of walk. However we did not found any study to explain it. Therefore the aim of this study is to investigate walking ability and limit of stability in children with spastic CP, and to compare their developing peers.

Interventions

OTHERGAITRite gaitway system, Bertec Balance System

GAITRite gaitway system will use to assess gait parameters, Bertec Balance System will use to assess limit of stability

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

6 Years to 15 Years

Healthy volunteers

Yes

Inclusion criteria

* spastic serebral palsy, between the ages 6-15 years, between the I-IV. levels of GMFCS, be able to understand command given by physical therapist

Exclusion criteria

* undergone botulinum toxin A to upper and/or lower extremities, undergone any surgery to their extremities, be at the V. levels of GMFCS

Design outcomes

Primary

Measure	Time frame	Description
Gait parameters (stride length in cm, step width in cm, time in swing phase in second, time in stance phase in second)	20 minutes	Gait parameters will be assessed by GAITRite walking way system.
Limit of stability when sitting and standing position in cm	20 minutes	Limit of stability will be evaluated by BERTEC balance system.

Countries

Turkey (Türkiye)

Contacts

Primary ContactBayram Sırrı, PT, MSc,

bayramsirri@gmail.com+905362410774

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026